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ABSTRACT 
Background: Common types of musculoskeletal conditions include pain in the neck and 
shoulder areas. This study seeks to identify the genetic variants associated with neck or 
shoulder pain based on a genome-wide association approach using 203,309 subjects from the 
UK Biobank cohort and look for replication evidence from the Generation Scotland: Scottish 
Family Health Study (GS:SFHS) and TwinsUK. 
Methods: A genome-wide association study was performed adjusting for age, sex, BMI and 
9 population principal components. Significant and independent genetic variants were then 
sent to GS:SFHS and TwinsUK for replication.  
Results: We identified 3 genetic loci that were associated with neck or shoulder pain in the 
UK Biobank samples. The most significant locus was in an intergenic region in chromosome 
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddaa058/5815552 by guest on 10 April 2020
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
3 
 
17, rs12453010, having P = 1.66 x 10-11. The second most significant locus was located in the 
FOXP2 gene in chromosome 7 with P = 2.38 x 10-10 for rs34291892. The third locus was 
located in the LINC01572 gene in chromosome 16 with P = 4.50 x 10-8 for rs62053992. In 
the replication stage, among 4 significant and independent genetic variants, rs2049604 in the 
FOXP2 gene and rs62053992 in the LINC01572 gene were weakly replicated in GS:SFHS (P 
= 0.0240 and P = 0.0202, respectively).  
Conclusions: We have identified 3 loci associated with neck or shoulder pain in the UK 
Biobank cohort, two of which were weakly supported in a replication cohort. Further 
evidence is needed to confirm their roles in neck or shoulder pain.  
 
 
INTRODUCTION 
Musculoskeletal pain in the neck and shoulder areas is a major health problem for adults of 
working age as well as for elderly populations (1). Neck and shoulder pain are prevalent 
forms of self-reported musculoskeletal pain (2). The aetiologies of neck and shoulder pain 
may be complicated since both regional lesions and systemic disorders outside the 
cervicobrachial area may cause pain at that location (3,4). In addition, lesions in the neck can 
lead to pain in the shoulder and vice versa (5). Many people also have difficulty in describing 
and differentiating pain in these areas accurately. For these reasons, neck or shoulder pain is 
often discussed as a single entity (6).  
Epidemiological studies have suggested that the prevalence of neck pain is 5-8% and 13% for 
shoulder pain (7–9). The Global Burden of Disease Study 2010 found that of the 291 
conditions studied, neck or shoulder pain as a single entity ranked 21st in overall burden on 
society, and 4th in terms of overall disability (8). The updated Global Burden of Disease 
Study 2016 also indicated that neck pain was a top five cause of years lived with disability 
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(YLD) in high-income, and high-middle-income countries (10). Risk factors associated with 
neck or shoulder pain conform to the biopsychosocial model; specifically, they include older 
age, being female, high body mass index (BMI), previous injury, strenuous occupation and 
diabetes mellitus (3,11–14). Although mechanical exposure is associated with increased risk 
of pain in the neck and shoulder, this explains only part of these complaints (15). Because of 
the biopsychosocial factors involved, treating neck or shoulder pain successfully is a 
challenge. In a study of neck, shoulder and arm pain, only 25% of the patients made a 
complete recovery after 6 months (16). This is lower than the 35% recovery rate of patients 
with low back pain after 12 months (17). Estimated rates of remission 1 year after neck or 
shoulder pain onset were between 33-55% (18–21).  
Genetic studies have identified genes associated with neck or shoulder pain. Twin studies 
have shown that there is a genetic role in neck pain (14), though in keeping with many traits 
the genetic component becomes smaller with age (22,23). Nonetheless, in adolescents as 
much as 68% of variance in neck pain liability could be attributed to genetic factors (24). So 
far there has been no genome-wide association study (GWAS) published on neck or shoulder 
pain. 
This study seeks to identify the genetic variants associated with neck or shoulder pain based 
on a GWAS approach in a cohort of 203,309 subjects from the UK Biobank cohort and to test 
significant results for replication in the Generation Scotland: Scottish Family Health Study 
(GS:SFHS) and TwinsUK. Similar approaches have been used to examine back pain, knee 
pain, and headaches in the UK Biobank cohort (25–27). 
 
RESULTS 
GWAS Results 
In the UK Biobank, 775,252 responses to all options were received for the specific pain 
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question. Of the 501,708 participants in the study, 123,061 participants reported having 
experienced activity limiting pain in the neck or shoulder in the previous month. 213,408 
participants chose the „None of the above‟ option which meant they did not have activity 
limiting pain anywhere in the previous month. To create a homogeneous dataset, we first 
removed samples according to their ancestry information. In addition, those who were related 
to one or more others in the cohort (a cut-off value of 0.044 in the generation of the genetic 
relationship matrix) and those who failed quality control were also removed. The final 
number of those included in the case group after the above exclusions was 53,994 (28,093 
males, 25,901 females). 149,312 (71,480 males, 77,832 females) individuals were included in 
the control group. After single-nucleotide polymorphism (SNP) quality control, there were 
9,304,965 SNPs available for GWAS analysis. Clinical characteristics of the case and control 
groups were compiled (Table 1). Age, sex, and BMI were all found to be significantly 
different (P < 0.001) between cases and controls. Three genetic loci including 4 significant 
and independent SNPs reached a GWAS significance of P < 5×10-8 (Figure 1, Table 2). The 
most significant locus was located in an intergenic region in chromosome 17. The SNP from 
this location of highest significance was rs12453010 (P = 1.66 x 10-10). The second locus was 
found in the FOXP2 gene located in chromosome 7, and the most significant SNP from this 
locus was rs34291892 (P = 2.38 x 10-10). The third locus was the LINC01572 gene located in 
chromosome 16, and the most significant SNP in this locus was rs62053992 (P = 4.50 x 10-
10). The SNP heritability (liability scale) from genome-wide complex trait analysis (GCTA) 
was 0.11+0.017.  
These 4 significant and independent SNPs were tested for replication in GS:SFHS and 
TwinsUK. Among 20,032 subjects in the GS:SFHS subjects, 19,598 had complete relevant 
information. The whole-genome fastGWA results did not find any SNPs with GWAS 
significance associated with neck or shoulder pain. (Supplementary Figure S1). Among the 4 
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SNPs from the discovery cohort, rs2049604 in the forkhead box protein P2 (FOXP2) gene 
and rs62053992 in the Long Intergenic Non-Protein Coding RNA 1572 (LINC01572) gene 
were replicated weakly (P = 0.0240 and 0.0202, respectively) (Table 2). Of the 6,921 
individuals in TwinsUK with genetic information, 3,982 of them had valid relevant 
information on phenotypes and covariates. None of the 4 SNPs were replicated in the 
TwinsUK cohort (P > 0.05). The clinical characteristics of the GS:SFHS and TwinsUK 
cohorts are summarised in Supplementary Table S1.  
Meta-analysis of the 4 significant and independent hits, combining UK Biobank, GS:SFHS 
and Twins UK found that the significance of their associations was increased (Table 2).  
FUMA Analysis 
In gene-based association analysis by MAGMA, 26 genes were found to be associated with 
neck or shoulder pain, all of which are represented in Supplementary Table S2. The most 
significant gene was FOXP2 (P = 1.62 x 10-11), which is located in chromosome 7.  
In gene-set analysis conducted by MAGMA, 10,651 gene-sets were analysed using the 
default competitive test model. None of these gene-sets met genome-wide significance (P < 
4.7 x 10-6 (0.05/10651)).  
Tissue expression analysis was conducted by GTEx, and the relationship between tissue 
specific gene expression and genetic associations was tested by using the average gene 
expression in each tissue type as a covariate. Two analyses were carried out, one investigating 
30 general tissue types (Figure 2) and the other looking at 53 specific tissue types (Figure 3). 
Tissue expression analysis in 30 tissue types found expression in brain tissue to be the most 
significant (P = 9.53 x 10-5). Only expression in brain and pituitary tissue reached significant 
values of P < 1.67 x 10-3 (0.05/30). Tissue expression analysis of 53 specific tissue types by 
GTEx found expression in the nucleus accumbens of the basal ganglia to be the most 
significant (P = 3.55 x 10-5). In addition, the top 6 significant associations were all from brain 
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddaa058/5815552 by guest on 10 April 2020
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
7 
 
tissues. 
The genetic correlation analysis using the LD hub (v1.9.0) showed that symptoms of 
depression had the largest significant and positive genetic correlation with neck or shoulder 
pain (rg = 0.5522, P = 3.41 x 10-30), followed by insomnia (rg = 0.5377, P = 1.21 x 10-21). It 
was also found that the age at which they have their first child had the most significant and 
negative genetic correlations with neck or shoulder pain (rg = -0.4812, P = 8.95 x 10-37), 
followed by college completion (rg = -0.4706, P = 7.26 x 10-26). All the phenotypes with 
significant genetic correlation with neck or shoulder pain are shown in Table 3. 
 
 
DISCUSSION  
We have performed a GWAS on neck or shoulder pain using the UK Biobank resource and 
found 3 loci that have reached genome-wide significance (P <0.05 × 10-8). They are the 
FOXP2 gene in chromosome 7, the LINC01582 gene in chromosome 16 and an intergenic 
area in chromosome 17. In the replication stage, the FOXP2 and LINC01582 loci were 
weakly supported by the GS:SFHS cohort, but not by TwinsUK. 
FOXP2 belongs to the forkhead-box transcription factor family and encodes a 715 amino acid 
long transcription factor (28). It may have 300-400 transcription targets, and has a 
forkhead/winged helix binding domain with 2 polyglutamine tracts adjacent to each other due 
to a mixture of CAG and CAA repeats (29,30). Both rs2049604 and rs34291892 are intronic 
variants and rs34291892 is an Indel type variant. We searched these 2 SNPs in the GTEx 
portal, but did not obtain any information on their impact on gene expression or gene 
function. FOXP2 is a gene shown to be vital in the neural mechanisms underpinning the 
development of speech and language. A previous study described a family with 
developmental verbal dyspraxia, where affected individuals had a loss of function mutation in 
the FOXP2 gene (31). Affected individuals in the family had difficulty with the selection and 
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sequencing of fine orofacial muscular movements needed to articulate words, as well as 
deficits in language and grammatical skills. FOXP2 also plays a role in regulating „hub‟ 
genes Dlx5 and Syt4 in animal models, which are important for brain development and 
function (32–34). The mutations in the FOXP2 gene were also associated with decreased grey 
matter in the cerebellum (35).  
Notably, FOXP2 is expressed in several regions of the brain, namely the basal ganglia, locus 
coeruleus, parabrachial nucleus, and thalamus. All of these regions have been previously 
implicated in the modulation of pain (36–39), and also concur with the tissue expression 
analysis (Figure 2, Figure 3) which suggests that the central nervous system modulates neck 
or shoulder pain. A recent GWAS study suggested that FOXP2 was significantly associated 
with multisite chronic pain (40). Further studies into the location and function of the 
transcription targets of FOXP2 would also provide valuable insight. 
The LINC01572 gene in chromosome 16 was also replicated in this study, with rs62053992 
having the P value at 4.5×10-8 in the discovery cohort and at 0.02 in the GS:SFHS. The gene 
is 384kb long, and was recently suggested to be related with polycystic ovary syndrome (41). 
However, studies of this gene have been very limited. Further replication evidence should be 
sought to confirm its role in neck or shoulder pain. Although the locus in chromosome 17 
was not replicated, it was the most significantly associated in the discovery cohort with 
rs12453010 having the lowest P value of 1.66 x 10-11.  The meta-analysis also showed that 
the effects of the SNP from the GS:SFHS and TwinsUK cohorts were in the same direction as 
UK Biobank. Analysis of this locus is also difficult as it is a gene desert. The nearest non 
protein-coding gene is LOC105371829, and is unlikely to be linked with neck or shoulder 
pain as its expression was observed only in testis and liver 
(https://www.ncbi.nlm.nih.gov/gene/105371829#gene-expression). The nearest protein 
coding gene is CA10, which encodes a protein belonging to the carbonic anhydrase family 
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and is responsible for catalysing the hydration of carbon dioxide. It is also thought to 
contribute to central nervous system development particularly in the brain (43). 
The results of the meta-analysis of the 4 significant and independent SNPs combining 3 
cohorts suggested that the loci identified by the UK Biobank cohort were supported by the 
GS:SFHS and TwinsUK. It is likely that the sample size in the TwinsUK (N= 3,982) was too 
small to replicate the loci for such a heterogeneous phenotype as neck or shoulder pain. In 
particular, for the 4 SNPs chosen for replication, the power to achieve a P value < 0.05 in the 
given TwinsUK sample ranged between 11.6% to 15.8% (44). 
The SNP heritability of neck or shoulder pain was 0.11. This is similar to that of back pain 
(0.11), greater than knee pain (0.08), multisite chronic pain (0.10), and less than hip pain 
(0.12), stomach or abdominal pain (0.14), headache (0.21), facial pain (0.24), and pain all 
over the body (0.31) (40,45). Further, the genetic correlation matrix among 8 pain phenotypes 
in UK Biobank showed that the neck or shoulder pain and back pain shared the highest 
genetic correlation (rg = 0.83) (45). The heritability of neck or shoulder pain in this study was 
significantly less than that reported in the teenage Finnish twin study (24). Such a difference 
between twin-based heritability and SNP-based heritability is common and usually 
attributable to 1) the effects of rare and other forms of variants not imputed / not taken into 
account in GWAS; and 2) the fact that twin studies may overestimate heritability due to gene-
gene and gene-environment interactions. Also, heritability of neck pain is known to be age-
dependant, with genetic effects decreasing with age (22). Age differences between the 
Finnish teenagers and our cohorts likely contributed to the difference in heritability estimates. 
The genetic correlation analysis results were perhaps to be expected. Like knee pain and back 
pain, which have been shown to be positively correlated with depression and neuroticism 
(45), neck or shoulder pain was correlated genetically and positively with some mental health 
and personality phenotypes. We also identified that neck or shoulder pain was genetically and 
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negatively correlated with the age at which they have their first child, college completion, and 
years of schooling. This means that those who were older when they had their first child, 
those with more years of schooling, and those with completed college education were less 
likely to report neck or shoulder pain.  These factors could be related to a number of factors 
including lifestyle, deprivation levels, and occupation. It is interesting to note that males are 
more likely to report neck or shoulder pain than females in the UK Biobank population. This 
is matched with the fact that males are more likely to have strenuous occupations. However, 
we should note that female sex is a risk factor for neck or shoulder pain. It is also noted that 
the cases were older and had higher BMI than the controls in the UK Biobank. 
The primary limitation of this study is that different (albeit similar) case and control 
definitions were used in the discovery and replication cohorts. This was a consequence of the 
pre-determined phenotypic information that was present in the relevant cohorts.  We defined 
neck or shoulder pain cases and controls based on the responses by UK Biobank participants 
to a specific pain question. This question focused on neck or shoulder pain occurrence during 
the previous month that was sufficient to cause interference with activity. The severity, 
frequency, and exact location of the neck or shoulder pain were not documented. Hence, our 
phenotyping should be considered as broadly defined. In the GS:SFHS and Twins UK 
cohorts, the disease status of participants was also self-reported: while cases were those who 
reported neck or shoulder pain over the previous 3 months; controls included those who 
reported neck or shoulder pain for less than 3 months, or pain of any duration in other body 
sites, as well as those reporting no pain. However, in the UK Biobank, controls were defined 
as pain free for the previous month. Differences between (albeit similar) case and control 
definitions could have a negative impact on the power of the replication study and the 
replication results while this impact is hard to evaluate. There could also be some cases who 
report neck or shoulder pain as a result of underlying causes such as cancer and osteoarthritis 
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in the neck and shoulder areas. Their impact on the results would be very limited due to the 
small numbers. In addition, as the cases and controls in the UK Biobank were self-reported, 
there could be some bias, for example from social desirability, recall period, sampling 
approach, or selective recall  (46). Further, although GTEx covered much expression 
information on different brain tissues, it does not report relevant expression information on 
musculoskeletal tissue or dorsal root ganglia which would also be of interest.   
In summary, we have identified 3 loci of genome-wide significance (P < 5×10-8) associated 
with neck or shoulder pain in the UK Biobank dataset using a GWAS approach. Two of these 
loci were replicated weakly in the GS:SFHS cohort. Identification of these loci now provides 
a foundation for future work into understanding genetic roles and aetiology in neck or 
shoulder pain.  
 
MATERIALS AND METHODS 
Participants and the genetic information of cohorts 
Discovery cohort - The UK Biobank (https://www.ukbiobank.ac.uk/) is a project facilitating 
research into health and disease and involves over 500,000 participants aged between 40-69 
years old at recruitment. Participants completed a detailed questionnaire which examined 
lifestyle, demographic factors, and clinical history. Participants also underwent clinical 
measures and baseline body measurements such as height and weight. Biological samples 
including urine, saliva, and blood were also provided. The National Research Ethics Service 
granted ethical approval to the UK Biobank (reference 11/NW/0382). The genetic 
information of 500,000 participants was released to approved researchers in March 2018. The 
corresponding author of this paper was granted access to the genetic information under UK 
Biobank application number 4844. Detailed quality control information pertaining to these 
genotypes was described by Bycroft et al (47). 
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Replication cohort 1 - Generation Scotland: Scottish Family Health Study (GS:SFHS) is a 
multi-institutional, family-based cohort involving over 20,000 volunteer participants aged 
between 18-98 years old at recruitment, who provided blood samples from which DNA was 
extracted. Similarly, participants also completed questionnaires to provide detailed 
phenotypic and sociodemographic information. Clinical and biochemical measurements were 
also collected for the purpose of research. Permission was obtained for linkage of research 
data to routine health data in the form of electronic health records (48,49). Ethical approval 
for GS:SFHS was obtained from the Tayside Committee on Medical Research Ethics (on 
behalf of the National Health Service) with reference Number 05/S1401/89. The genetic 
information relating 20,000 participants was released to the corresponding author of this 
paper in March 2018 for pain-related research. Detailed quality control information 
pertaining to these genotypes was described by Hall et al (50).  
Replication cohort 2 - The TwinsUK cohort is a UK nationwide registry of volunteer same 
sex twins. It has recruited 14,274 registered twins aged between 16 and 98 years. Collection 
of data and biological materials commenced in 1992 and is ongoing. During study 
participation, participants regularly complete health and lifestyle questionnaires and visit 
collaborating clinics and hospitals for clinical evaluation. Ethical approval was provided by 
the Research Ethics Committee at Guy‟s and St. Thomas‟ NHS Foundation Trust. TwinsUK 
has the genetic information relating to 6,921 participants. Detailed quality control 
information pertaining to the genetic information was described by Moayyeri et al (51). 
Phenotypic definitions on neck or shoulder pain 
Discovery cohort - UK Biobank: Participants were offered a pain-related questionnaire, 
which included the question: „in the last month have you experienced any of the following 
that interfered with your usual activities?‟. The options were: 1. Headache; 2. Facial pain; 3. 
Neck or shoulder pain; 4. Back pain; 5. Stomach or abdominal pain; 6. Hip pain; 7. Knee 
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pain; 8. Pain all over the body; 9. None of the above; 10. Prefer not to say. Participants could 
select more than one option. (UK Biobank Questionnaire field ID: 6159). 
In this study, cases were defined as participants who reported having activity limiting pain in 
the neck or shoulder in the past month (option 3), regardless of whether they reported pain in 
other regions. The controls were defined as participants who chose the „None of the above‟ 
option. 
Replication cohort 1 – GS:SFHS: Participants were first asked „‟Are you currently troubled 
by pain or discomfort, either all the time or on and off?‟‟. If yes was selected, then the 
participants were asked „‟Have you had this pain or discomfort for more than 3 months?‟‟. If 
yes was selected once again, then they were asked „‟Where is this pain or discomfort?‟‟ with 
options of „Back pain‟, „Neck or shoulder pain‟, „Headache, facial or dental pain‟, „Stomach 
ache or abdominal pain‟, „Pain in your arms, hands, hips, legs or feet‟, „Chest pain‟, and 
„Other pain‟. If a participant selected the „Neck or shoulder pain‟, then he/she was defined as 
a case. All other subjects were defined as controls. 
Replication cohort 2: TwinsUK: participants were asked „In the past three months, have you 
had pain in your neck or shoulders?‟ Those who answered „Yes‟ were defined as cases. Those 
who answered „No‟ were defined as controls. Those with missing answers were not included 
in the study. 
Statistical Analysis  
Discovery cohort – UK Biobank: BGENIE (https://jmarchini.org/bgenie/) was used as the 
main GWAS software.  SNPs with imputation INFO scores < 0.1, minor allele frequency 
(MAF) < 0.5% were removed, as well as SNPs that failed Hardy-Weinberg tests P < 1.0 x 10-
6. 
BGENIE was used to perform association studies using linear association tests, adjusting for 
age, sex, BMI, 9 population principle components, genotyping arrays, and assessment 
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centres. Chi-square testing was used to compare gender difference between cases and 
controls. T-tests were used to compare age and BMI between case and control groups using 
IBM SPSS 22 (IBM Corporation, New York). As is standard in GWAS, SNP associations 
were considered significant when P < 5.0 x 10-8. GCTA software was used to calculate SNP-
based or narrow-sense heritability (52). Only significant and independent SNPs from the 
discovery GWAS were sent to replication cohorts for replication. These significant and 
independent SNPs were defined by FUMA with r2 (linkage disequilibrium score) < 0.6 with 
any other significant SNPs.  
Replication cohort 1 – GS:SFHS: GCTA fastGWA1.92.4 was the main software used for 
replication (https://cnsgenomics.com/software/gcta/#fastGWA). SNPs with INFO scores < 
0.3, or MAF < 1% were removed, as well as SNPs that failed Hardy-Weinberg tests P < 1.0 x 
10-6. FastGWA was used to perform association studies using a mixed-effects linear model 
adjusting for age, sex, BMI, and 9 population principal components. Relatedness was 
adjusted for via a genetic kinship matrix.  
Replication cohort 2 – TwinsUK: GEMMA v 0.98.1 was used for replication 
(https://github.com/genetics-statistics/GEMMA). A mixed-effects linear model adjusting for 
age, sex, BMI, and relatedness via a genetic kinship matrix was used. 
Meta-analysis of the significant and independent SNPs combining the UK Biobank, 
GS:SFHS and TwinsUK was performed using GWAMA 2.2.2 
(https://genomics.ut.ee/en/tools/gwama).  
Post-GWAS analysis: This study used FUMA as a main annotation tool for viewing and 
annotating GWAS results (53). It applied SNP functional annotations and generated a 
corresponding GWAS Manhattan plot. 
MAGMA v1.06 (integrated in FUMA) was used to perform gene-based association analysis 
and gene-set analysis, both of which were generated from GWAS summary statistics (54). 
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For gene-based association analysis, all SNPs located in protein coding genes are mapped to 
one of 19,123 protein coding genes. The default SNP-wise model (mean) was applied. We 
tested the joint association of all SNPs in the gene with the phenotype by aggregating the 
SNP summary statistics to the level of whole genes. In gene-set analysis, individual genes 
were aggregated to groups of genes sharing certain biological, functional or other 
characteristics. This aims to elucidate the involvement of specific biological pathways or 
cellular functions in the genetic aetiology of a phenotype. GTEx (also integrated in FUMA, 
https://www.gtexportal.org/home/) provided the results of tissue expression analysis.  
Genetic correlation analysis was also performed to identify genetic correlation between neck 
or shoulder pain and 234 complex traits based on the online tool LD hub v1.9.0 
(http://ldsc.broadinstitute.org/ldhub/). Any P value less than 2.1 x 10-4 (0.05/234) was 
considered statistically significant by Bonferroni adjusted testing. 
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Figure 1: The Manhattan plot of the GWAS on neck or shoulder pain using the UK Biobank 
cohort (N=203,309). The dashed red line indicates the cut-off P value of 5 × 10-8. 
 
Figure 2: Tissue expression results on 30 specific tissue types by GTEx in the FUMA. The 
dashed line shows the cut-off P value for significance with Bonferroni adjustment for 
multiple hypothesis testing. 
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Figure 3: Tissue expression results on 53 specific tissue types by GTEx in the FUMA. The 
dashed line shows the cut-off P value for significance with Bonferroni adjustment for 
multiple hypothesis testing. 
 
Table 1. Clinical characteristics of neck or shoulder pain cases and controls in the UK 
Biobank  
 UK Biobank   
Covariates Cases Controls P  
Sex (male:female) 28093 (52.0%) : 
25901 (48.0%) 
71,480 (47.9%) : 
77,832 (52.1%) 
<0.001 
Age (years) 57.7 (7.82)  
 
56.9 (7.97) 
 
<0.001 
BMI (kg/m2) 27.8 (4.85) 26.7 (4.30) <0.001 
BMI: body mass index 
A chi-square test was used to test the difference of gender frequency between cases and 
controls and an independent t test was used for other covariates. 
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Continuous covariates were presented as mean (standard deviation). 
  
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddaa058/5815552 by guest on 10 April 2020
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
28 
 
 
Table 2. The summary statistics of the 4 significant and independent SNPs in the UK 
Biobank and the replication and meta-analysis results using the GS:SFHS and TwinsUK 
cohorts  
 
rs3
429
189
2 
was 
repl
ace
d 
by 
rs4
727799 (r2=0.8736) as it does not exist in the GS:SFHS and TwinsUK cohorts.  
UK Biobank N=203,309; GS:SFHS N= 19,632; TwinsUK N= 3,982 
Chr: chromosome 
MAF: minor allele frequency 
Significant P values in the replication (P < 0.05) were in bold 
  
   UK 
Biobank 
Discovery 
stage 
   GS:SF
HS 
replica
tion 
  Twins
UK 
replica
tion 
  Meta
-
analy
sis 
  
SNP C
hr 
Positio
n 
MAF P beta se P beta se P beta se P effe
cts 
I
2 
rs2049
604 
7 113990
352 
0.3648 (T) 3.26 x 
10-8 
-
0.00
80 
0.00
15 
0.0240 -
0.00
88 
0.00
39 
0.13 -
0.01
88 
0.01
22 
3.19 
x 10-
9 
--- 0 
rs3429
1892 
7 114058
731 
0.3772 
(C) 
2.38 x 
10-10 
-
0.00
92 
0.00
14 
0.1068 -
0.00
64 
0.00
39 
0.11 -
0.01
96 
0.01
24 
7.07 
x 10-
12 
--- 0 
rs6205
3992 
16 723898
72 
0.1819 
(G) 
4.50 x 
10-8 
-
0.00
98 
0.00
18 
0.0202 -
0.01
09 
0.00
47 
0.94 0.00
12 
0.01
58 
4.36 
x 10-
9 
--+ 0 
rs1245
3010 
17 503161
31 
0.3926 (T) 1.66 x 
10-11 
0.00
95 
0.00
14 
0.1331 0.00
58 
0.00
38 
0.10 0.01
99 
0.01
21 
2.20 
x 10-
12 
+++ 0 
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Table 3.  The significant genetic correlation results by the LD hub between neck or shoulder 
pain with other phenotypes   
 
rg: genetic correlation 
The cut-off P value is 0.0002 (0.05/234). 
 
Trait 1 Trait 2 rg P 
Neck or shoulder pain Depressive symptoms 0.5522 3.41 x 10-30 
Neck or shoulder pain Insomnia 0.5377 1.21 x 10-21 
Neck or shoulder pain Neuroticism 0.4417 2.00 x 10-29 
Neck or shoulder pain Major depressive disorder 0.3968 5.75 x 10-08 
Neck or shoulder pain Ever vs never smoked 0.3082 4.14 x 10-08 
Neck or shoulder pain Number of children ever born 0.2616 2.03 x 10-07 
Neck or shoulder pain Coronary artery disease 0.1965 1.66 x 10-07 
Neck or shoulder pain Waist-to-hip ratio 0.1547 1.31 x 10-05 
Neck or shoulder pain Sleep duration -0.2468 9.46 x 10-07 
Neck or shoulder pain Subjective well being -0.2626 1.14 x 10-06 
Neck or shoulder pain Intelligence -0.3229 2.23 x 10-17 
Neck or shoulder pain Former vs Current smoker -0.3600 5.87 x 10-06 
Neck or shoulder pain Years of schooling 2016 -0.4373 5.18 x 10-54 
Neck or shoulder pain College completion -0.4706 7.26 x 10-26 
Neck or shoulder pain Age of first birth -0.4812 8.95 x 10-37 
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